Neumora Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Watertown, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Neumora Therapeutics, Inc. has filed 257 SEC EDGAR filings since 08 Nov 2021

SEC filing history

Showing 151-175 of 257 matching filings.

Per page
25
Current page
7
DEFA14A File 001-41802

DEFA14A

Filing date
25 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-41802

DEF 14A

Filing date
25 Apr 2024
Reporting date
13 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Apr 2024
Reporting date
22 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-277748

S-8

Filing date
07 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Feb 2024
Reporting date
14 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Feb 2024
Reporting date
14 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Feb 2024
Reporting date
14 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Feb 2024
Reporting date
14 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Feb 2024
Reporting date
14 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Feb 2024
Reporting date
14 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Feb 2024
Reporting date
14 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94162

SC 13G

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94162

SC 13G filing

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-94162

ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D/A(#1)

Filing date
15 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
12 Dec 2023
Reporting date
08 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
12 Dec 2023
Reporting date
08 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
12 Dec 2023
Reporting date
08 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Dec 2023
Reporting date
11 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .